These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 3788331)

  • 1. [Significance of carcinoembryonic antigen in the treatment of colorectal cancers].
    Putzki H
    Zentralbl Chir; 1986; 111(18):1119-23. PubMed ID: 3788331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CEA determination in the follow-up of colorectal cancers].
    Lauterbach M; Dehne A; Hesse V; Höfig G
    Zentralbl Chir; 1987; 112(15):968-74. PubMed ID: 3673304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma.
    Kohler JP; Simonowitz D; Paloyan D
    Am Surg; 1980 Aug; 46(8):449-52. PubMed ID: 7406353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of CEA in the early diagnosis of colorectal cancer recurrence in the light of second-look results].
    Colombo PL; Lovotti D; Franco F; Coronelli M; Bonacasa R
    Minerva Med; 1986 Mar; 77(13):495-8. PubMed ID: 3703341
    [No Abstract]   [Full Text] [Related]  

  • 5. CEA radioimmunoassay. Clinical applications in colorectal cancer.
    Huyghe J
    Acta Chir Belg; 1983; 83(2):77-88. PubMed ID: 6858539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
    Quentmeier A; Schlag P; Herfarth C
    Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective follow-up study of radically resected colorectal carcinoma. Status after 5 years].
    Metzger U; Bronz K; Bühler H; Dolder A; Seefeld U; Hollinger A; Largiadèr F
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1001-4. PubMed ID: 4048893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].
    Kato K; Morimoto T; Kato T; Yasue M; Takagi H; Kito T; Nakazato H; Miyaishi S; Yamada E; Kuwabara M; Suchi T
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1137-42. PubMed ID: 7229472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of 2d look operations in colorectal cancers].
    Pelikán A
    Zentralbl Chir; 1986; 111(18):1109-12. PubMed ID: 3788330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 12. [Colorectal cancer recurrence. Early diagnosis by determination of a carcinoembryonic antigen in the serum].
    Johnson JA; Giercksky KE
    Tidsskr Nor Laegeforen; 1985 Oct; 105(29):2044-6. PubMed ID: 4071492
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum.
    Cohen AM; Wood WC
    Surg Gynecol Obstet; 1979 Jul; 149(1):22-6. PubMed ID: 451823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer.
    Steele G; Zamcheck N
    Cancer Detect Prev; 1985; 8(3):421-7. PubMed ID: 4064062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient carcinoembryonic antigen (CEA) elevations following resection of colorectal cancer: a limitation in the use of serial CEA levels as an indicator for second-look surgery.
    Rittgers RA; Steele G; Zamcheck N; Loewenstein MS; Sugarbaker PH; Mayer RJ; Lokich JJ; Maltz J; Wilso RE
    J Natl Cancer Inst; 1978 Aug; 61(2):315-8. PubMed ID: 277718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value and limits of the determination of carcinoembryonic antigen (CEA) in postoperative evaluation of patients with colonic and rectal carcinomas].
    Jaeger P; Pettavel J; Wuilleret B; Bertholet MM; Mach JP
    Schweiz Med Wochenschr; 1975 Nov; 105(46):1533-8. PubMed ID: 1220002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].
    Metzger U; Decurtins M; Joller H; Grob PJ; Largiadèr F
    Schweiz Med Wochenschr; 1983 Apr; 113(15):548-9. PubMed ID: 6857209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is the clinical significance of CEA determination in patients with colorectal carcinoma exaggerated?].
    Wedell J; Meier zu Eissen P; Meier zu Eissen J; Blanco A; van Calker H; Koldowski P; Schlipköter HW
    Med Welt; 1981 Mar; 32(11):343-7. PubMed ID: 7219141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.